University of New Mexico Cancer Research & Treatment Center

The University of New Mexico (UNM) Comprehensive Cancer Center received funding from the New Mexico state legislature in 1971 and, in 2003, the legislature designated it as the official cancer center of New Mexico. In 2005, it became New Mexico’s only NCI-Designated Cancer Center and in 2015 it received the comprehensive cancer center designation.

To ensure that all New Mexicans have access to world-class cancer care and benefit from advances in cancer research, the UNM Comprehensive Cancer Center aims to provide outstanding cancer diagnosis and treatment, conduct world-class research to discover the causes and the cures for cancer, educate the next generation of cancer health care professionals, and overcome the significant cancer health disparities in the Southwest through community-based outreach programs.

The UNM Comprehensive Cancer Center has established research collaborations with Lovelace Biomedical, Sandia National Laboratories, Los Alamos National Laboratory, and New Mexico State University. Lovelace Biomedical is a consortium partner of the Center, bringing complementary expertise in the causes, mechanisms, and detection of lung cancer and drug development.

The UNM Comprehensive Cancer Center is committed to providing compassionate, cutting-edge, multidisciplinary cancer care to all New Mexicans. At the Center, New Mexicans have access to chemotherapy, radiation therapy, cancer surgery, genetic cancer assessment, clinical trials, supportive care, and a pharmacy under one roof. The facility has 17 clinic and service lines, including New Mexico’s only bone marrow and stem cell transplant program, which offers autologous and allogeneic transplants; theranostic treatments for neuroendocrine and prostate cancers; and advanced radiation therapy.

Read more about the University of New Mexico Cancer Research & Treatment Center.